Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

Add to Collection

2012 Oct Systematic Review and Meta Analysis RJ Stevens, R Ali, CR Bankhead, MA Bethel, BJ Cairns… - Diabetologia, 2012 - Springer 164

Full Author : ['Stevens, R J', 'Ali, R', 'Bankhead, C R', 'Bethel, M A', 'Cairns, B J', 'Camisasca, R P', 'Crowe, F L', 'Farmer, A J', 'Harrison, S', 'Hirst, J A', 'Home, P', 'Kahn, S E', 'McLellan, J H', 'Perera, R', 'Pluddemann, A', 'Ramachandran, A', 'Roberts, N W', 'Rose, P W', 'Schweizer, A', 'Viberti, G', 'Holman, R R']
Journal Title : Diabetologia
Chapter : Section3
Journal Year : 2012
Cited by : 205.0

AIMS/HYPOTHESIS: Observational studies suggest that metformin may reduce cancer risk by approximately one-third. We examined cancer outcomes and all-cause mortality in published randomised controlled trials (RCTs). METHODS: RCTs comparing metformin with a..... Read More

Keywords : ["randomised clinical trial", "metformin systematic review", "collaborative metaanalysis", "cancer outcome", "allcause mortality", "adult allocate"]
PubMed Link : https://link.springer.com/article/10.1007/s00125-012-2653-7
Google Scholar Link : https://scholar.google.com/scholar?cites=11484342071122116264&as_sdt=5,34&sciodt=0,34&hl=en&num=20

Have a Question?

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.